Back to search
FDAFDA · Food and drugs·Recall number D-0176-2023

S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch, Manufactured By: Nephron West Columbia, SC 29172, NDC 0487-5901-99 UPC 3 04875 90199 9

Published February 1, 2023 · Recall initiated: January 13, 2023

Summary

FDA records drug Class II recall D-0176-2023, published February 1, 2023 and initiated January 13, 2023. Recalling firm: Nephron Sc Inc; Status: Terminated; Reported quantity: 925,920 vials; Lot: Lot #: 126461, 126431 Exp. 04/30/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Short Fill

What to do

Voluntary: Firm initiated · Letter

Get an email if S2 has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
S2
Manufacturer
Nephron Sc Inc
Distributor
Nationwide within the United States including Puerto Rico. Guatamala
UPC
304875901999
Lot
Lot #: 126461, 126431 Exp. 04/30/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch, Manufactured By: Nephron West Columbia, SC 29172, NDC 0487-5901-99 UPC 3 04875 90199 9 recalled?

Yes. FDA published recall D-0176-2023 on February 1, 2023. Reported hazard: Short Fill

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: S2. UPC: 304875901999.